ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Oasmia Appoints Head of Clinical Development & Head of Regulatory Affairs
August 27, 2021Oasmia Pharmaceutical AB, an oncology-focused specialty pharmaceutical company, today announces the appointments of Kia Bengtsson as Head of Clinical Development and Johanna Röstin as Head of Regulatory Affairs with effect from October 1, 2021. -
Kazia Licenses Cantrixil, a Clinical-stage, First-in-class Ovarian Cancer Drug Candidate, to Oasmia Pharmacetical AB
March 02, 2021Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into an exclusive worldwide license agreement with Oasmia Pharmaceutical AB (STO: OASM).
Pharma Sources Insight January 2025
